UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Oceaneering
OII
$5.09B
| $1.87M | ﹤0.01% |
105,812
+23,548
| +29% | +$454K |
|
|
CSGS
1627
DELISTED
CSG Systems International
CSGS
| $1.86M | ﹤0.01% |
34,679
+3,607
| +12% | +$205K |
|
1628
Valaris
VAL
$5.94B
| $1.86M | ﹤0.01% |
28,598
+1,804
| +7% | +$126K |
|
1629
US Physical Therapy
USPH
$1.24B
| $1.86M | ﹤0.01% |
18,998
+1,137
| +6% | +$108K |
|
1630
Sally Beauty Holdings
SBH
$1.57B
| $1.86M | ﹤0.01% |
119,362
-8,587
| -7% | -$133K |
|
1631
iShares Russell 1000 Growth ETF
IWF
$127B
| $1.86M | ﹤0.01% |
30,400
+25,200
| +485% | +$1.45M |
|
1632
Tennant Co
TNC
$1.18B
| $1.85M | ﹤0.01% |
27,021
+201
| +0.7% | +$13.6K |
|
|
SAGE
1633
DELISTED
Sage Therapeutics
SAGE
| $1.85M | ﹤0.01% |
44,077
+1,985
| +5% | +$85.3K |
|
1634
Upstart Holdings
UPST
$2.94B
| $1.85M | ﹤0.01% |
116,375
+5,974
| +5% | +$101K |
|
1635
Northern Oil and Gas
NOG
$2.56B
| $1.85M | ﹤0.01% |
60,954
+2,191
| +4% | +$68.3K |
|
1636
Renasant Corp
RNST
$3.9B
| $1.84M | ﹤0.01% |
+60,139
| New | +$2.1M |
|
1637
Fastly Inc
FSLY
$4.42B
| $1.83M | ﹤0.01% |
103,208
-8,042
| -7% | -$102K |
|
1638
Donnelley Financial Solutions
DFIN
$1.17B
| $1.83M | ﹤0.01% |
44,713
| – | – |
|
1639
Middlesex Water
MSEX
$1.09B
| $1.83M | ﹤0.01% |
23,378
+2,548
| +12% | +$206K |
|
1640
Towne Bank
TOWN
$3.4B
| $1.83M | ﹤0.01% |
68,516
-3,417
| -5% | -$101K |
|
1641
Veracyte
VCYT
$3.72B
| $1.83M | ﹤0.01% |
81,872
+2,243
| +3% | +$54.2K |
|
1642
Hims & Hers Health
HIMS
$7.35B
| $1.82M | ﹤0.01% |
183,780
+24,701
| +16% | +$216K |
|
1643
Marqeta
MQ
$1.62B
| $1.82M | ﹤0.01% |
99,582
-6,423
| -6% | -$143K |
|
1644
Telephone and Data Systems
TDS
$3.84B
| $1.82M | ﹤0.01% |
173,063
+47,177
| +37% | +$550K |
|
1645
Wolverine World Wide
WWW
$1.55B
| $1.82M | ﹤0.01% |
106,503
+7,403
| +7% | +$113K |
|
1646
Jack in the Box
JACK
$340M
| $1.81M | ﹤0.01% |
20,720
+2,828
| +16% | +$224K |
|
1647
Pricesmart
PSMT
$5.21B
| $1.81M | ﹤0.01% |
25,274
+1,531
| +6% | +$107K |
|
1648
JetBlue
JBLU
$2.13B
| $1.8M | ﹤0.01% |
247,750
-2,670
| -1% | -$21.1K |
|
1649
Weis Markets
WMK
$1.78B
| $1.8M | ﹤0.01% |
21,211
+977
| +5% | +$81.8K |
|
1650
Monro
MNRO
$368M
| $1.79M | ﹤0.01% |
36,304
+956
| +3% | +$47.5K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.